Open AccessP947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB‐LENALIDOMIDE‐DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)‐BASED INDUCTION VS PARENTERAL V‐BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
Author(s) -
Rifkin R. M.,
Costello C. L.,
Birhiray R. E.,
Kambhampati S.,
Richter J.,
Abonour R.,
Lee H. C.,
Kim Y. J.,
Ren K.,
Stull D. M.,
Cherepanov D.,
Bogard K.,
Noga S. J.,
Girnius S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846656.55700.df
Subject(s) - medicine , ixazomib , cohort , multiple myeloma , bortezomib , lenalidomide , oncology , proteasome inhibitor , surgery , carfilzomib